CMS Signals Major Shift in Payment Policies for Clinical Software and AI in Healthcare
The Centers for Medicare & Medicaid Services (CMS) has signaled its intent to revamp how it pays for clinical software and artificial intelligence tools used in healthcare settings. This move could have significant implications for how medical technology companies develop and price their products, as payment structures from CMS often set standards that private insurers also follow.
The announcement suggests that CMS is looking to create more streamlined and updated pathways for reimbursing digital health tools, including AI-powered diagnostic and clinical support systems. Healthcare technology advocates have long argued that existing Medicare payment policies are often slow to adapt to rapidly evolving software and AI capabilities, creating barriers to innovation and patient access.
The proposed changes could address several longstanding challenges, including how to classify software as a medical device for reimbursement purposes and how to evaluate the value of AI tools that learn and improve over time. Industry stakeholders are expected to engage with CMS during the rulemaking process as details of the new payment framework are developed.